Persistence of immunity and impact of a third (booster) dose of an inactivated SARS-CoV-2 vaccine, BBV152; a phase 2, double-blind, randomised controlled trial
暂无分享，去创建一个
K. Ella | P. Yadav | P. Abraham | G. Sapkal | J. Kushwaha | R. Ella | K. M. Vadrevu | H. Jogdand | S. Prasad | S. Reddy | B. Ganneru | S. Verma | C. Singh | S. Redkar | C. S. Gillurkar | S. Rai | U. Praturi | R. Dugyala | P. Reddy | S. Mohapatra | A. Bhate